☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Post-Transplant
Takeda Receives the US FDA Advisory Committee's Recommendation for TAK-620 (maribavir) to Treat CMV Infection in Post-Transplant R...
October 8, 2021
Takeda Report Results of TAK-620 (maribavir) in P-III SOLCTICE Trial for the Treatment of Post-Transplant Patients with Cytomegalo...
February 15, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.